Tumour size, axillary lymph node involvement, grade as defined by Elston & Ellis, Estrogen Receptor (ER) status, Progesterone Receptor (PR) status and HER2 status are routine determinants of the breast cancer prognosis. This evidence concerns the gene ERBB2 and breast carcinoma.